The AERIS Airway transforms the practice of moderate to deep sedation by providing superior oxygen delivery and real-time, reliable CO2 monitoring, thereby limiting the risk of hypoxia in patients.
Deer Park and Sycamore, Illinois – January 8, 2026 – Airway Innovations, Inc. of Deer Park, Illinois, a medical device company dedicated to advancing patient care through innovative airway management solutions, announced that an exclusive distribution agreement has been entered into with MED Alliance Group of Sycamore, Illinois, a leading distributor of breakthrough medical technologies, for its AERIS Airway™ device. MED Alliance Group has an extensive network of sales representatives with proven expertise in bringing specialized anesthesia-related products to hospitals and surgery centers across the Midwest and East Coast. This partnership will dramatically expand AERIS Airway's reach and availability to anesthesia providers.
“Securing this agreement with MED Alliance Group marks a major milestone for Airway Innovations,” stated Paul Fehrenbacher, CEO of Airway Innovations. “From the outset, it was clear that MED Alliance Group shared our dedication to advancing clinical excellence and patient safety by delivering innovative devices directly to the patient’s bedside. Their strong distribution network and relationships with anesthesiologists and CRNAs will play a pivotal role in establishing the AERIS Airway as the standard of care for moderate to deep I.V. sedation procedures.”
The AERIS Airway directly addresses persistent challenges in airway management by delivering optimal oxygen levels and real-time, reliable ventilation monitoring during moderate to deep I.V. sedation. This innovation supports improved patient safety and streamlines anesthesia providers' workflow, while reducing overall costs.
Early feedback from anesthesiologists and CRNAs at recent conferences has been overwhelmingly positive, underscoring the AERIS Airway's strong potential for broad clinical adoption. Michael Schroeder, President of MED Alliance Group commented, "We are excited to add the AERIS Airway to our portfolio. This remarkable technology has the power to improve patient outcomes and overcome the traditional clinical challenges of using face masks and nasalcannulas during I.V. sedation.
We are eager to work alongside the Airway Innovations team and introduce this device to anesthesia providers who demand better solutions in airway management."
About Airway Innovations
Airway Innovations is a privately held medical device company focused on developing and commercializing innovative solutions for airway management that improve patient safety, streamline the workflow of anesthesia providers, and decrease healthcare costs.
About MED Alliance Group
MED Alliance Group is a medical device distributor that has been meeting the needs of our clinical customers and manufacturing partners since 1998. We specialize in the sales, marketing, importation, logistics and distribution of innovative, high-quality and cost-effective products found in anesthesia and respiratory, blood and transfusion therapy, EMS and emergency room, interventional radiology and cath lab, iv and vascular, as well as NICU and PICU.
Airway Innovations Contact:
Chris Klecher, SVP Marketing
chris.klecher@airwayinnovations.com
949.310.8271
MED Alliance Group Contact:
Christie Penzol, Marketing Director
cpenzol@medalliancegroup.com
630-443-7070 x112